Menopause has become one of the busiest corners of health podcasting, and hormone therapy is the subject where its shows differ most. In the UK, Dr Louise Newson hosts a weekly podcast from her menopause clinic and treats HRT as the starting point. In the US, Selene Yeager's Hit Play Not Pause brings gynecologists on for practical, unhurried interviews aimed at active women, while The Peter Attia Drive and The Mel Robbins Podcast reach far bigger audiences with one-off conversations featuring trial investigators and urologists. Each show has a house view, so a listener who samples all four hears the consensus and the open arguments within a few weeks. This guide picks the episodes worth your time on each part of the subject, beginning with a Women's Health Initiative investigator explaining her own trial.
If you want the history first (the 2002 Women's Health Initiative scare and the slow correction that followed), start with our guide to menopause and perimenopause podcasts. This piece picks up where that one stops.
Risk: the trial explained by the people who ran it
The single best hour on risk is The Peter Attia Drive #253 (May 2023), with JoAnn Manson, one of the principal investigators of the Women's Health Initiative itself. Hearing the study explained by someone who ran it is rare. Manson walks through the trial design, why the average participant was older than most women who start treatment, and how the breast cancer headline outran the data.
For a counterweight, play Hit Play Not Pause's conversation with Professor Susan Davis of Monash University ("Should We All Be On Hormone Therapy?", July 2024). Davis is firmly in favor of treating symptoms, yet she pushes back on the newer idea that every woman should take hormones to protect her heart and brain. Medical societies recommend therapy for symptoms and for preventing bone loss, and none of them endorse it as general disease prevention. Listening to Manson and Davis back to back gives you the mainstream position from two angles.
That mainstream view is written down in The Menopause Society's 2022 position statement: for healthy women under 60, or within ten years of their last period, the benefits of hormone therapy generally outweigh the risks.
Patch, gel or pill: UK and US shows give different defaults
On this question you can hear an ocean between the podcasts. The Dr Louise Newson Podcast treats estradiol through the skin (patch, gel or spray) as the default, mainly because it avoids the small rise in clot risk linked to oral estrogen. Newson's critics accept that point; their disagreement with her is about dose and about how far hormones should be pushed beyond symptom relief.
On Hit Play Not Pause, Dr. Carla DiGirolamo has two practical episodes, "A Candid Conversation About Hormone Therapy" (October 2024) and "Managing Side Effects" (March 2025). Both cover how doctors adjust the form and dose when the first prescription causes breast tenderness, headaches or mood changes. That part is often skipped, and it matters, because many women who stop treatment do so in the first few months for exactly these reasons.
Progestogens: the episodes for women who struggle with them
The progestogen episodes draw some of the most grateful listener mail, because this is where many women run into trouble. Anyone who still has a uterus needs a progestogen alongside estrogen to protect the womb lining. Newson's episode 110, "Can't tolerate progesterone? It may be progestogens" (October 2026), with biochemist Dr. Phyllis Bronson, separates body-identical micronized progesterone from the synthetic progestins found in older HRT and in many contraceptive pills. Her episode 57, "Bleeding on HRT: what's normal and what's not" (April 2026), answers the question that sends many women back to their doctor in the first year.
On the US side, urologist Rachel Rubin covers the same ground in two places: The Peter Attia Drive #348 (May 2025) and a long interview on The Mel Robbins Podcast in March 2026. Robbins called it one of the most important conversations she has had on the show. Rubin is especially strong on vaginal estrogen, which treats dryness and recurrent urinary infections at very low doses and is suitable for many women who avoid systemic hormones.
Starting after 60: one clinician's case, and a middle ground
Many women are told that the window closes at 60, and Newson has used her podcast to argue against that rule. Her solo episode 59, "Can you start HRT after 60? What the evidence shows" (April 2026), argues that it often does not, and she pairs it with episode 73 on continuing treatment after 70. Treat these as one clinician's case. The position statement above is more cautious about starting late, especially for women with heart disease risk factors, so this is a conversation to have with your own doctor using your own numbers.
Dr. Mary Claire Haver's interview on Huberman Lab (June 2024) is a useful middle ground. She covers body composition, sleep and training together with HRT, and she is careful about what the breast cancer and cardiovascular data can and cannot show.
When hormones are off the table: what Hit Play Not Pause teaches
Women with some hormone-sensitive cancers, a history of clots, or simply no wish to take hormones get very little airtime. Hit Play Not Pause episode 291, "Estrogen, Interrupted" (September 2026), is built for them. Drs. Rebecca Dunsmoor-Su and Amy Voedisch explain who really should avoid hormone therapy, which old rules no longer apply, and how the newer non-hormonal drugs work. Veozah and Lynkuet act on the brain circuit that triggers hot flashes. The episode also covers why vaginal estrogen is rarely ruled out, even for many women who cannot use systemic therapy.
For a clinician-facing summary, The International Menopause Society publishes short expert talks, including "Menopause and Hormone Therapy: Current Perspectives and Controversies" (October 2024) in two versions, one for women and one for health professionals.
The menopause supplements in the ad breaks
Every menopause feed carries ads for capsules promising to ease hot flashes, belly fat or brain fog. Most rely on black cohosh, red clover, soy isoflavones or blends of adaptogens, and the trials behind them are small and inconsistent. Black cohosh has also been linked to rare cases of liver injury. If a product's main claim is that it "balances hormones", ask what it actually contains and at what dose, and tell your doctor if you take it alongside prescribed HRT.
Where these shows disagree
The fault lines are worth knowing before you listen. Newson pushes hardest for treatment, including testosterone for women, and argues that hormones protect long-term health. Attia's guests and the society talks sit closer to guideline medicine. Hit Play Not Pause is the most pragmatic of the group, focusing on what helps an active woman feel and perform well. Hearing all three is more useful than settling on one voice, and it will prepare you for a better conversation at your appointment.
Last updated: 2 November 2026.
This article is for general information and is not medical advice. Talk to a doctor or other qualified clinician about your own situation before starting, changing or stopping any treatment.